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INVESTIGATIONS of human melanoma
growth are mostly limited to characteriza-
tion of growth properties of established
cell lines (Giovanella et al., 1976; Meyskens
& Fuller, 1980; Meyskens et al., 1980) or
cells maintained in nude mice (Selby et al.,
1980; Giovanella et al., 1976). Only a few
studies (Fuller & Meyskens, 1981; Sherwin
et al., 1979; Fisher et al., 1976; Kitano,
1976) have examined the role of hormones
on human melanoma cell growth.
We have recently applied a clonogenic
tumour cell-assay developed in our labora-
tory (Hamburger & Salmon, 1977) to
human melanoma, and have characterized
clonogenic human melanoma cells (Meys-
kens, 1980) and measured the effect of
retinoids (Meyskens & Salmon, 1979) and
chemotherapeutic agents (Salmon et al.,
1980) on their growth. Effects ofhormonal
agents in this system would also be of
interest.
The neural-crest origin of melanocytes
suggests that melanoma cells might be
influenced by trophic factors which affect
neuronal cells. We report here the modu-
lating effect of follicle-stimulating hor-
mone (FSH), melatonin, and nerve growth
factor (NGF) on the growth of clonogenic
human melanoma cells in fresh biopsy
samples.
FSH (porcine) and melatonin were
obtained from Sigma Chemicals and NGF
(7S) from Collaborative Research, and
stored at - 80°C as lyophilized powders or
concentrated stock solutions. Immedi-
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ately before use the hormones were
diluted with Ham's FIO culture medium
(Gibco) to twice the desired final concen-
tration and incorporated into the upper
plating layer containing the tumour
biopsy cells. The effects of these hormones
were evaluated over the following concen-
tration ranges: FSH (10-12-10-4 g/ml),
melatonin (10-15-10-5M), and NGF (0410-
20 u/ml).
Malignant-melanoma metastaticnodules
obtained from patient biopsies were the
source of cells for these investigations.
The studies were approved by the Human
Subjects Committee, University of
Arizona. The general methodology has
been extensively described elsewhere
(Salmon et al., 1978; Meyskens & Salmon,
1979; Salmon et al., 1980). Absolute cell
numbers were determined by haema-
cytometer and viable counts assessed by
trypan-blue exclusion. No enzymatic pro-
cedures were used.
Assessment of cells was performed on
colonies in dried agar slide preparations
(Salmon & Buick, 1979) by analysis of the
stained preparations for morphology
(Papanicolaou, 1954) and melanin
(Mishima, 1960). Two major morphologic-
ally distinct types of colonies were dis-
tinguished and separately counted. The
2 major colony variants were (a) groups
of 20-100 light, large (25-35pkm diameter)
cells and (b) groups of 40-200 dark
(melanotic), small (8-20[km diameter)
cells. Detailed characterization and dis-F. L. MEYSKENS, JR AND S. E. SALMON
tribution of these colony types is pre-
sented elsewhere (Meyskens, 1980). The
cytological features of these 2 colony
types are depicted in Fig. 1.
Control and hormone-treated cultures
were serially examined by phase micro-
scopy for changes in the number of
colonies produced from a tumour-cell
suspension. A melanoma colony in our
assay is designated as a contiguous group
of cells arising from a single cell and con-
taining > 50 cells. Groups of cells contain-
ing 8-50 cells were frequently seen, but
were not counted as colonies. The mean
cloning efficiency in control plates was
0-012% of all cells plated, but 0.031% of
the melanocytes as analysed in Papani-
colaou and melanin-stained cell prepara-
tions.
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FIG. 1.-Morphological and pigmentary
colony variants of human melanoma grown
in soft agar. Two distinct types of colonies
can be grown: light, large-cell and dark,
small-cell.
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FIG. 2. Modulation of clonogenic human
melanoma cells by neurohormones (Patient
G). Three different neurohormones pro-
duced a switch from light, large-cell
colonies to dark, small-cell colonies.
Panel: a. FSH; b. Melatonin; c. NGF.
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TABLE.-Response ofclonogenic melanoma cells to neurohormones
Type of
colony in Effect of hormone on cloning efficiency
control , -
Patient
A
B
C
D
E
F
G
H
I
J
K
cultures
LL
LL/DS
LL/DS
LL
LL
LL/DS
LL
LL
LL
LL/DS
LL
FSH*
ND
ND
ND
(4,LLt t-DS)
NR
t
Melatonin
4,t
NR
( 4,LL t t DS)
NR
NR
NGF
(,LL t DS)
(4,LL tDS)
NR
ND
ND
(4 LL t DS)
ND
NR
1'
* Abbreviations: FSH (porcine follicle-stimulating hormone), NGF (murine nerve growth factor), LL (light,
arge-cell colonies), DS (dark, small-cell colonies).
tSymbols: 4,, < 75% of control;
4, LL t DS, decrease in cloning efficiency of LL colonies at low concentrations of NGF with switch
to DS colony variant and increased cloning efficiency of the DS variant at increasing NGF concentrations
(see Fig. 2c);
4 > 150% ofcontrol;
4, LL 4 t DS, decrease in LL variant and increase in DS variant, as shown in Figs 2a, b.
ND, Not done.
NR, No response.
The response to FSH of clonogenic
melanoma cells from 8 different patients
varied (Table, Fig. 2a). In 5/8 cases colony
formation of both colony types was
reduced. There was no evidence for a
change in the morphological types of
colony. In 2 patients (G, J) FSH increased
cloning efficiency. In Patient J both
colony variants increased to twice the
number of colonies in the control cultures.
In Patient G a switch from the light,
large-cell to dark. small-cell colony
variant occurred, and the total number of
this variant increased over 6-fold over the
total number ofcolonies seen in the control
cultures. In both Patients G and J, the
size of the colonies at concentrations of
FSH from 10-9 to 10-6 g/ml was 2-3 times
that seen in controls.
The response of clonogenic melanoma
cells from 11 different patients to mela-
tonin was tested. In 3 patients no effect
was seen. In 6/11 cases total cloning
efficiency was decreased with increasing
concentrations ofmelatonin. No change in
colony type or in average diameter of the
colonies was seen (data not shown). In 2
8*
patients (G and J) of the 11 cases tested
stimulation of melanoma colony forma-
tion by melatonin was seen. In Patient J,
control cultures contained both types of
colony variant, which were increased
greater than 4-fold of controls at 10-9M
melatonin. In Patient G a switch from
light, large-cell colonies to dark, small-cell
colonies was seen (Fig. 2b). Control cul-
tures contained few dark, small-cell
colonies, but with increasing concentra-
tions of melatonin, this colony variant
increased, and the light-large, cell colonies
were apparently suppressed. At 10-11M
melatonin the dark, small-cell colonies
increased to over 9-fold over the total
colonies seen in control plates. The re-
sponse was biphasic, with a decrease in
the number of colonies at concentrations
of melatonin > 10-llm.
The response to NGF of clonogenic
melanoma cells from 8 patients was
examined (Table, Fig. 2c). Clonogenic
cells from 2 patients (D and J) demon-
strated no response to NGF. In Patients
B, J and K, melanoma colony formation
was inhibited by increasing concentrations
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of NGF, and no change in the expression
of the types or sizes ofthe colony variants
were recorded. In Patients A, C and G
(Fig. 2c) the response to NGF was more
complex; the light, large-cell colony
variant was predominant in control cul-
tures. Both colony variants were affected
by NGF, and with increasing concentra-
tions the light, large-cell variant was
inhibited and the dark, small-cell colonies
were increased. In none ofthe 3 cases were
the dark, small-cell variants increased
> 20% above the total number of colonies
seen in the control cultures.
The commonest effect of these 3 trophic
factors on clonogenic melanoma cells from
these 11 patients was to reduce the total
cloning efficiency (5/8 patients with FSH,
6/11 with melatonin, and 3/8 with NGF)
(Table). In these patients no response was
seen in 6 cases (1 of 8 with FSH, 3/11 with
melatonin and 2/8 with NGF).
In 4 instances (FSH, 2/8 patients and
melatonin, 2/11 patients) a marked in-
crease in cloning efficiency was seen.
The clonogenic cells of all 3 patients
(A, C, G) who responded to NGF by
inhibition of growth of the light, large-cell
colonies and stimulation of growth of the
dark, small-cell colonies demonstrated
responsiveness to both melatonin (3/3) and
FSH (2/2) of cells from the 3 patients
(B, I, K) which manifest only inhibition
of total clonogenicity by NGF no re-
sponse to melatonin in 2/3 cases and to
FSH in 1/2 cases demonstrated.
The clonogenic cells from the 8 patients
(A, B, C, E, F, G, H, J) which responded
to melatonin usually responded also to
FSH (4/5) or NGF (4/5). In contrast, the
clonogenic cells of the 3 patients (D, I, K)
which did not respond to melatonin were
affected less frequently by FSH (1/2 pati-
ents) and NGF (1/3 patients).
Our studies demonstrate thatthegrowth
of clonogenic human melanoma cells can
be modulated by FSH, melatonin and
NGF. Additionally, the ability of these
compounds in some cases to induce
clonogenic melanoma cells to form one
type of colony as opposed to another
suggests that these hormones might play
a role in the regulation of clonal growth:
however, these investigations do not indi-
cate at what level of the clonal hierarchy
that these hormones act.
The possible role of FSH, melatonin,
and NGF in modulating clonogenic melan-
oma cells suggests to us that when
melanocytes become malignant they may
re-express a variety ofembryonic antigens
and functions related to their neural-crest
pluripotentiality. However, it is possible
that all melanocytes respond to these
agents, but since no system exists for
culturing normal melanocytes this ex-
planation is untestable.
Our results clearly indicate that FSH,
melatonin, and NGF affect clonogenic
human melanoma cells and suggest that
manipulation ofthese hormones may offer
a new avenue to explore in the clinical
management of malignant melanoma. We
speculate that the heterogeneous clinical
nature of melanoma may be related to the
expression of responses to trophic hor-
mones related to the neural-crest origin of
melanocytes and, thus, that the biological
behaviour of melanoma may be explicable
(or at least classifiable) in terms of par-
ticular trophic hormone responses.
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